AST Announces Availability of Quick-Delivery Isolated Fill-Finish Equipment
AST is excited to announce the availability of quick-delivery of the most popular isolated equipment within 6 months of purchase.
AST is excited to announce the availability of quick-delivery of the most popular isolated equipment within 6 months of purchase. Download our case study to learn more about AST’s latest project with Catalent. AST, a leading aseptic fill- and finishing machine manufacturer, and SCHOTT, a global expert in drug containment solutions, share their expertise on how to help 503(b) compounding facilities bring acute care drugs to market quicker, provide a safer drug administration process, and minimize healthcare and hospital costs. Today, new drug products and multi-product facilities demand higher precision and flexibility than ever before. Sheila Dell, Ph.D, discusses automated technology and how it can improve sterility assurance and data integrity in the compounding sector. AST’s Matthew Gorton offers insights on solutions to common problems in small batch production AST’s latest whitepaper on robotics, now available for download.Whitepaper
AST Announces Availability of Quick-Delivery Isolated Fill-Finish Equipment
Providing Flexible Aseptic Solutions: The AST Way
Considerations for Pre-filled Syringes for 503(b) Compounding Facilities
Reinventing your Aseptic Processing
Improve Sterility Assurance And Data Integrity 503B Compounding
Overcome the Challenges of Small Batch Production
The Advantages Of Robotics In Aseptic Fill Finish